文献速递皮肤肿瘤

OCA2/HERC2基因变异影响实体器官移植受者首次皮肤鳞状细胞癌发生时间

Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs.
PubMed 文献 · Br J Dermatol · 2017-09-08

本研究在两个中心的实体器官移植受者中评估OCA2/HERC2基因变异对首次皮肤鳞状细胞癌发生时间的影响。这是首个显示该基因座变异与移植后cSCC发生时间相关的研究。

要点

  • OCA2/HERC2变异与移植后首次cSCC时间相关。
  • 棕眼等位基因纯合者cSCC发生延迟。
  • 可能影响高危人群皮肤筛查建议。

核心结论

  • OCA2/HERC2基因座变异与实体器官移植受者移植后首次cSCC发生时间显著相关。

研究设计与样本

  • 俄亥俄州立大学研究为病例对照设计结合前瞻性随访。
  • 加州大学旧金山分校研究为全国横断面调查结合回顾性病历审查。
  • 所有参与者均有DNA用于基因分型,并有医疗记录和问卷数据。

临床怎么用

  • OCA2/HERC2变异可能用于识别移植后cSCC高风险患者,影响皮肤筛查建议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Variants at the oculocutaneous albinism 2 (OCA2)/HECT and RLD domain containing E3 ubiquitin protein ligase 2 (HERC2) locus have been associated with pigmentation phenotypes and risk of developing several types of skin cancer. OBJECTIVES: To evaluate OCA2/HERC2 locus variants for their impact on time to develop cutaneous squamous cell carcinoma (cSCC) in organ transplant recipients (OTRs) who are at elevated risk of developing cSCC. METHODS: Participants were solid OTRs ascertained from two centres (n = 125 and 261) with an average of 13·1 years of follow-up post-transplant. DNA was available for genotyping for all participants, in addition to medical records and questionnaire data. The Ohio State University study had a case-control design with prospective follow-up, and the University of California San Francisco study was a national cross-sectional survey with retrospective chart review. RESULTS: OCA2 variants rs12913832 and rs916977 were significantly associated with time to first cSCC post-transplant. OTRs homozygous for the brown-eye alleles of rs916977 (GG) and rs12913832 (AA) had significant delays of time to first cSCC post-transplant compared with individuals homozygous for the blue-eye alleles (hazard ratio 0·34, P < 0·001 and hazard ratio 0·54, P = 0·012, respectively). Both variants were highly associated with eye colour in the combined studies (P < 0·001). CONCLUSIONS: This study is the first to show an association between OCA2/HERC2 variants and time to first cSCC post-transplant. This may impact dermatological screening recommendations for high-risk populations.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Wei L, Allain DC, Bernhardt MN, et al. Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs. Br J Dermatol. 2017. PMID: 28456133. doi:10.1111/bjd.15618

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。